Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy

X Thomas Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, FranceCorrespondence[email protected]

QH Le Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Service de Biostatistiques, Centre Hospitalier Lyon Sud Pierre-Bénite, France

S de Botton Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Claude Huriez, Lille, France

E Raffoux Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Saint Louis, Paris, France

Y Chelghoum Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, France

C Pautas Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Henri Mondor, Créteil, France

F Dreyfus Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Cochin, Paris, France

N Dhedin Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Groupe Hospitalier Pitié-Salpétrière, Paris, France

A Vekhoff Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôtel-Dieu, Paris, France

J Troncy Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, France

A Pigneux Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital du Haut Levêque, Pessac, France

T de Revel Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital d'Instruction des Armées Percy, Clamart, France

O Reman Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Georges Clémenceau, Caen, France

P Travade Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital de l'Hôtel-Dieu, Clermont-Ferrand, France

A Thiebaut Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, France

A Guerci Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital de Brabois, Vandoeuvre, France

M Elhamri Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, France

P Fenaux Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Claude Huriez, Lille, France

H Dombret Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Saint Louis, Paris, France

M Michallet Department of Hematology, Hôpital Edouard Herriot, Lyon, France; Department of Hematology, Hôpital Edouard Herriot, Lyon, France

show all

Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy

Information for

Open access

Opportunities

Help and information

Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature